ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy.
Onco Targets Ther
; 10: 4859-4867, 2017.
Article
in En
| MEDLINE
| ID: mdl-29042797
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Onco Targets Ther
Year:
2017
Document type:
Article
Country of publication:
New Zealand